Targeted-release budesonide therapy for IgA nephropathy

Lancet. 2017 Dec 16;390(10113):2625. doi: 10.1016/S0140-6736(17)32145-1.

Authors

Kenji Tsuda¹, Tetsuya Tanimoto², Jinichi Mori², Kazuhiro Kosugi³, Tsunehiko Komatsu⁴

Affiliations

¹ Teikyo University Chiba Medical Center, Chiba 299-0111, Japan. Electronic address: thedod3@hotmail.com.
² Jyoban Hospital, Tokiwa Foundation, Fukushima, Japan.
³ Kawasaki Municipal Ida Hospital, Kanagawa, Japan.
⁴ Teikyo University Chiba Medical Center, Chiba 299-0111, Japan.

PMID: 29256403
DOI: 10.1016/S0140-6736(17)32145-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Budesonide*
Glomerulonephritis, IGA*
Humans

Substances

Budesonide